A Retrospective Observational Study Evaluating Changes In Glycemic Control In Adult Patients With Type 2 Diabetes Mellitus (T2DM) and Treated With Canagliflozin Using The Inovalon MORE2 (Medical Outcomes Research for Effectiveness and Economics) Registry Database.

Trial Profile

A Retrospective Observational Study Evaluating Changes In Glycemic Control In Adult Patients With Type 2 Diabetes Mellitus (T2DM) and Treated With Canagliflozin Using The Inovalon MORE2 (Medical Outcomes Research for Effectiveness and Economics) Registry Database.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2015

At a glance

  • Drugs Canagliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2015 New trial record
    • 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top